Summary: Researchers mapped the molecular landscapes of autism spectrum disorder (ASD) to determine how hundreds of diverse genetic mutations influence the developing brain. Using single‑nucleus multi‑omics sequencing, the team tracked gene expression and epigenetic changes across more than 250 individual tissue samples and multiple developmental stages, revealing common cellular targets and time‑limited disruptions in brain maturation.
Although the genetic causes of ASD are highly heterogeneous, different high‑risk mutations converge on the same brain cell types and molecular pathways during early development. The common alterations largely appear as transient delays in cellular maturation and synaptic connectivity rather than permanent structural defects, with many differences diminishing by around two weeks after birth in the mouse models studied.
The study also identified pronounced sex differences: female models often display markedly different molecular responses to ASD‑linked mutations than males. These results argue against a single, universal treatment for ASD and instead highlight the need for interventions tailored to developmental stage, sex, and the individual molecular trajectory.
Key Facts
- Convergent brain pathways: Diverse genetic mutations linked to autism affect the same brain cell types and molecular processes during early development.
- Transient maturation delays: Observed changes largely reflect temporary delays in cell maturation and connectivity, not permanent lineage misspecification.
- Sex-specific variation: Female models often show different and sometimes stronger molecular responses to high‑risk ASD mutations than male models.
- Single‑cell multi‑omics mapping: The study profiled over 250 individual nuclei, simultaneously measuring DNA, RNA activity, and epigenetic marks to resolve cell‑type specific effects.
- Critical intervention window: Many shared developmental differences begin to normalize by about two weeks after birth in mice, indicating a time‑sensitive opportunity for early therapies.
Source: ISTA
Background
Hundreds of genes have been implicated in autism, but exactly how these genetic changes translate into altered brain development has remained unclear. A new study led by Gaia Novarino at the Institute of Science and Technology Austria (ISTA) combined advanced single‑nucleus multi‑omics techniques with comprehensive sampling across developmental stages, sexes and brain regions to chart the cellular and molecular dynamics shared across multiple monogenic mouse models of ASD.
“Autism spectrum conditions are neurodevelopmental disorders with diverse clinical presentations, often including intellectual disability or epilepsy. The underlying changes begin in early brain development, while behavioral signs commonly emerge in early childhood,” explains Gaia Novarino, Professor and Executive Vice President at ISTA.
A central question has been whether the many genetic causes of ASD ultimately produce similar neurobiological changes. Lena Schwarz, an ISTA alumna and lead author of the study, together with colleagues from ISTA, the Medical University of Vienna, the University of Vienna and CeMM, set out to compare molecular signatures across multiple genetic models and developmental time points to identify shared and distinct mechanisms.
Methods: single‑nucleus multi‑omics
The team used single‑nucleus multi‑omics sequencing, which captures multiple molecular layers from individual cell nuclei: the genome (DNA), gene activity (RNA), and epigenetic marks that regulate gene expression. This single‑cell resolution allows researchers to determine which cell types are affected by specific mutations and how gene regulation and transcription change over development.
Schwarz analyzed over 250 nucleus samples from 11 monogenic mouse models of ASD, spanning two brain regions, three developmental stages and both sexes. This breadth enabled a systematic comparison of how different high‑risk genes perturb brain development at cellular and molecular levels.
Major findings
Despite the genetic diversity, ASD‑linked mutations converged on perturbations of the radial glial cell lineage and early neuronal programs. The dominant pattern was a transient developmental delay: radial glia and early neurons showed delayed maturation and downregulation of synaptic and ion channel genes at early postnatal stages, consistent with slowed neuronal maturation or compensatory homeostatic changes.
Network analyses revealed that convergence was stage‑specific: diverse mutations disrupted common processes within the same developmental windows, but this convergence became less pronounced by postnatal day 14 in mice. Electrophysiological recordings supported the molecular data, showing altered neuronal excitability and synaptic properties with model‑specific nuances.
Notably, the study detected strong sex differences in gene expression changes, with female mice often exhibiting larger effect sizes or qualitatively different responses to the same mutations. These differences underscore the importance of including both sexes in preclinical research and of designing sex‑aware therapeutic approaches.
Implications for therapy and research
The results suggest that rather than a single universal treatment, effective therapies for ASD may need to be tailored to the developmental stage, biological sex, and specific molecular trajectory of the individual. Shared, stage‑specific vulnerabilities—such as delays in radial glia maturation and early neuronal synaptic programs—represent promising targets for early intervention strategies aimed at supporting proper developmental timing and circuit formation.
“Our findings point toward stage‑, sex‑ and trajectory‑specific intervention strategies,” says Novarino. “By understanding the timing and cell types most affected across genetic models, we can better define when and how to intervene to support healthy brain development.”
Key Questions Answered:
A: No. Each genetic mutation leaves a distinct molecular fingerprint, but many mutations converge on the same brain cell types and developmental processes, especially during early postnatal stages. Diverse genetic factors therefore disrupt a shared core network of stage‑specific molecular programs.
A: The primary effect is a transient delay in cellular maturation and synaptic connectivity rather than permanent lineage changes. In the mouse models examined, many molecular differences began to normalize around two weeks after birth, indicating a flexible but time‑sensitive developmental window.
A: Because the biological impact of ASD‑linked mutations varies by developmental stage, genetic context and biological sex. Female brains can respond differently to the same mutations as male brains, so effective therapies will likely need to be tailored to these variables rather than relying on a one‑size‑fits‑all approach.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The full journal paper was reviewed.
- Additional context was added by staff editorship.
About this autism and genetics research news
Author: Andreas Rothe
Source: ISTA
Contact: Andreas Rothe – ISTA
Image: The image is credited to Neuroscience News
Original Research: Open access. “Cortical development dynamics across autism spectrum disorder mouse models” by Lena A. Schwarz, Christoph P. Dotter, Sergey Isaev, Michela Lisi, Daniel Malzl, Christoph Büschl, Sabrina Ladstätter, Bárbara Oliveira, Matteo Barel, Bernadette Basilico, Chaitanya Chintaluri, Sarah Gorkiewicz, Mohammad Goudarzi, Tereza Belinova, Stephan Reichl, Gintarė Sendžikaitė, Satish Arcot Jayaram, Peter Koppensteiner, Christoph Sommer, Tim P. Vogels, Jörg Menche, Igor Adameyko, Peter V. Kharchenko, Christoph Bock & Gaia Novarino. Nature. DOI: 10.1038/s41586-026-10679-1
Abstract
Cortical development dynamics across autism spectrum disorder mouse models
Despite the functional diversity of over 100 causal genes, phenotypic convergence across models may reveal common neurobiological processes in autism spectrum disorder (ASD). This study profiled 251 samples from 11 monogenic mouse models using single‑nucleus multi‑omic sequencing across three developmental stages, both sexes and two brain regions.
Despite genetic heterogeneity, ASD‑linked mutations converged on perturbations of the radial glial cell lineage. These alterations reflected a transient developmental delay rather than lasting lineage misspecification and largely resolved by postnatal stages. The largest transcriptional differences appeared in neurons at early postnatal stages and included downregulation of synaptic and ion channel genes, consistent with homeostatic adaptation or delayed maturation.
Network analysis showed molecular convergence across models within each developmental stage, indicating that diverse mutations impinge on common, stage‑specific processes. Convergence was less pronounced by postnatal day 14, highlighting the dynamic and time‑limited nature of ASD‑associated changes.
Cross‑genotype heterogeneity overlies stage‑specific effects. Electrophysiology corroborated this pattern: mutant models generally exhibited altered neuronal excitability and synaptic function with model‑specific differences. The study also reported sex‑specific gene expression alterations, with female mice often showing larger effect sizes than males. Together, these findings offer a comprehensive view of developmental cellular and molecular dynamics across ASD models.